From: Emerging role of RNA sensors in tumor microenvironment and immunotherapy
RNA sensors | Cancers | Effect on immune microenvironment | Outcome | References |
---|---|---|---|---|
TLR3 | NSCLC | DC, NK, CTL activation, macrophage M1 polarization | Suppression | |
 | Breast cancer | DC, CTL activation IL-12, IFN-γ production | Suppression | [28] |
 | Lung cancer | IL-1β release | Progression | [36] |
 | Melanoma | DC, NK cells activation PD-L1 decrease | Suppression | |
 | Colon cancer | Macrophage M1 polarization | Suppression | [31] |
 | Breast and lung cancer | Chemotactic signalling pathway | Progression | [40] |
TLR7 | Melanoma | TAM decrease | Suppression | [35] |
 | NSCLC | MDSCs recruitment | Progression, metastasis | [38] |
 | STAD | T cells, macrophages, NK and DC infiltration | Suppression | [42] |
TLR8 | Prostate cancer | CD8+ Treg cells suppression | Suppression | [46] |
 | Breast cancer | Gammadelta T cells, Treg, MDSCs suppression | Suppression | |
 | Melanoma | Treg cells suppression | Suppression | [50] |
 | Solid tumor cells | Tumor-induced T cell and DC senescence prevention, MDSCs apoptosis | Suppression | |
 | Head and neck cancer | MDSCs suppression, M1 monocyte and CD8+ T cells infiltration | Suppression | [54] |
RIG-I | Melanoma | CD8+ T cells, NK cells response | Suppression | |
 | Lung cancer | Reduction of exhausted CD8+ T cells | Suppression | [70] |
 | Hepatocellular carcinoma | Macrophages M1 polarization | Suppression | [61] |
 | Ovarian cancer | IFN production, PD-L1 over-expression | Progression | [63] |
 | Nasopharyngeal carcinoma | PD-L1 over-expression | Progression | [64] |
MDA5 | Melanoma | IFN and IL15 production, CTL expansion | Suppression | [65] |
 | Solid tumor cells | Th1 T cells differentiation, IFN response | Suppression | [66] |
LGP2 | Breast cancer | DC activation, IFN-1 production, CD8+ T cells infiltration | Suppression | [67] |
NOD2 | Lung adenocarcinoma | Macrophages M2 polarization | Progression | [71] |